{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T01:02:07Z","timestamp":1788224527647,"version":"build-2803163510"},"reference-count":32,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,5,21]],"date-time":"2026-05-21T00:00:00Z","timestamp":1779321600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,7,27]],"date-time":"2026-07-27T00:00:00Z","timestamp":1785110400000},"content-version":"vor","delay-in-days":67,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100003710","name":"Korea Health Industry Development Institute","doi-asserted-by":"crossref","award":["RS-2025-02263271"],"award-info":[{"award-number":["RS-2025-02263271"]}],"id":[{"id":"10.13039\/501100003710","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Soonchunhyang University Research Fund"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-026-54465-5","type":"journal-article","created":{"date-parts":[[2026,5,21]],"date-time":"2026-05-21T16:14:14Z","timestamp":1779380054000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Liver fibrosis burden and risk of incident arrhythmia in metabolic dysfunction-associated steatotic liver disease"],"prefix":"10.1038","volume":"16","author":[{"given":"Keungmo","family":"Yang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seung Hyun","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jaejun","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Young","family":"Chang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeong-Ju","family":"Yoo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sae Hwan","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Soung Won","family":"Jeong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sang Gyune","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jae Young","family":"Jang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Young Seok","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hong Soo","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yongeun","family":"Cho","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tom","family":"Ryu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,5,21]]},"reference":[{"key":"54465_CR1","doi-asserted-by":"publisher","first-page":"382","DOI":"10.3350\/cmh.2024.0987","volume":"31","author":"D Kim","year":"2025","unstructured":"Kim, D. et al. Current burden of steatotic liver disease and fibrosis among adults in the United States, 2017\u20132023. Clin. Mol. Hepatol. 31, 382\u2013393. https:\/\/doi.org\/10.3350\/cmh.2024.0987 (2025).","journal-title":"Clin. Mol. Hepatol."},{"key":"54465_CR2","doi-asserted-by":"publisher","first-page":"bvaf110","DOI":"10.1210\/jendso\/bvaf110","volume":"9","author":"F Bril","year":"2025","unstructured":"Bril, F., Bolla, P., Huynh, K. & Bobba, S. Prevalence of MASLD in people with diabetes has decreased in the US, but rates of liver fibrosis are still on the rise. J. Endocr. Soc. 9, bvaf110. https:\/\/doi.org\/10.1210\/jendso\/bvaf110 (2025).","journal-title":"J. Endocr. Soc."},{"key":"54465_CR3","doi-asserted-by":"publisher","unstructured":"Mustafa, A. et al. Cardiovascular disease in the context of metabolic dysfunction-associated steatotic liver disease (MASLD): A comprehensive narrative review. Int. J. Mol. Sci. 26 https:\/\/doi.org\/10.3390\/ijms262311275 (2025).","DOI":"10.3390\/ijms262311275"},{"key":"54465_CR4","doi-asserted-by":"publisher","first-page":"100786","DOI":"10.1016\/j.lanepe.2023.100786","volume":"37","author":"D Linz","year":"2024","unstructured":"Linz, D. et al. Atrial fibrillation: Epidemiology, screening and digital health. Lancet Reg. Health Eur. 37, 100786. https:\/\/doi.org\/10.1016\/j.lanepe.2023.100786 (2024).","journal-title":"Lancet Reg. Health Eur."},{"key":"54465_CR5","doi-asserted-by":"publisher","first-page":"101092","DOI":"10.1016\/j.arr.2020.101092","volume":"61","author":"L Bencivenga","year":"2020","unstructured":"Bencivenga, L. et al. Atrial fibrillation in the elderly: A risk factor beyond stroke. Ageing Res. Rev. 61, 101092. https:\/\/doi.org\/10.1016\/j.arr.2020.101092 (2020).","journal-title":"Ageing Res. Rev."},{"key":"54465_CR6","doi-asserted-by":"publisher","first-page":"S511","DOI":"10.33549\/physiolres.934744","volume":"70","author":"Z Carna","year":"2021","unstructured":"Carna, Z. & Osmancik, P. The effect of obesity, hypertension, diabetes mellitus, alcohol, and sleep apnea on the risk of atrial fibrillation. Physiol. Res. 70, S511\u2013S525. https:\/\/doi.org\/10.33549\/physiolres.934744 (2021).","journal-title":"Physiol. Res."},{"key":"54465_CR7","doi-asserted-by":"publisher","unstructured":"Meynet, I. et al. Management of device-detected subclinical atrial fibrillation: a European Heart Rhythm Association survey. Europace 27 https:\/\/doi.org\/10.1093\/europace\/euaf284 (2025).","DOI":"10.1093\/europace\/euaf284"},{"key":"54465_CR8","doi-asserted-by":"publisher","unstructured":"Tan, S. et al. Burden and age-specific trends of atrial fibrillation\/atrial flutter from 1990 to 2023: a growing challenge among younger and middle-aged adults. Europace 28 https:\/\/doi.org\/10.1093\/europace\/euag036 (2026).","DOI":"10.1093\/europace\/euag036"},{"key":"54465_CR9","doi-asserted-by":"publisher","first-page":"1360974","DOI":"10.3389\/fphar.2024.1360974","volume":"15","author":"B Zhong","year":"2024","unstructured":"Zhong, B. et al. Identification of key genes increasing susceptibility to atrial fibrillation in nonalcoholic fatty liver disease and the potential mechanisms: mitochondrial dysfunction and systemic inflammation. Front. Pharmacol. 15, 1360974. https:\/\/doi.org\/10.3389\/fphar.2024.1360974 (2024).","journal-title":"Front. Pharmacol."},{"key":"54465_CR10","doi-asserted-by":"publisher","first-page":"931","DOI":"10.1016\/j.jhep.2022.05.030","volume":"77","author":"LA van Kleef","year":"2022","unstructured":"van Kleef, L. A. et al. Liver stiffness not fatty liver disease is associated with atrial fibrillation: The Rotterdam study. J. Hepatol. 77, 931\u2013938. https:\/\/doi.org\/10.1016\/j.jhep.2022.05.030 (2022).","journal-title":"J. Hepatol."},{"key":"54465_CR11","doi-asserted-by":"publisher","unstructured":"Bharaj, I. S. et al. Metabolic-dysfunction associated steatotic liver disease and atrial fibrillation: A review of pathogenesis. World J. Cardiol. 17 https:\/\/doi.org\/10.4330\/wjc.v17.i6.106147 (2025).","DOI":"10.4330\/wjc.v17.i6.106147"},{"key":"54465_CR12","doi-asserted-by":"publisher","first-page":"S157","DOI":"10.3350\/cmh.2022.0348","volume":"29","author":"T Reinson","year":"2023","unstructured":"Reinson, T., Buchanan, R. M. & Byrne, C. D. Noninvasive serum biomarkers for liver fibrosis in NAFLD: current and future. Clin. Mol. Hepatol. 29, S157\u2013S170. https:\/\/doi.org\/10.3350\/cmh.2022.0348 (2023).","journal-title":"Clin. Mol. Hepatol."},{"key":"54465_CR13","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1002\/hep.21669","volume":"46","author":"A Vallet-Pichard","year":"2007","unstructured":"Vallet-Pichard, A. et al. FIB-4: an inexpensive and accurate marker of fibrosis in HCV infection. comparison with liver biopsy and fibrotest. Hepatology 46, 32\u201336. https:\/\/doi.org\/10.1002\/hep.21669 (2007).","journal-title":"Hepatology"},{"key":"54465_CR14","doi-asserted-by":"publisher","first-page":"e40214","DOI":"10.1097\/MD.0000000000040214","volume":"103","author":"M Chen","year":"2024","unstructured":"Chen, M., Guo, C., Ouyang, K. & Liu, N. Diagnostic role of the fibrosis-4 index and nonalcoholic fatty liver disease fibrosis score as a noninvasive tool for liver fibrosis scoring. Med. (Baltim). 103, e40214. https:\/\/doi.org\/10.1097\/MD.0000000000040214 (2024).","journal-title":"Med. (Baltim)."},{"key":"54465_CR15","doi-asserted-by":"publisher","first-page":"518","DOI":"10.1053\/jhep.2003.50346","volume":"38","author":"CT Wai","year":"2003","unstructured":"Wai, C. T. et al. A simple noninvasive index can predict both significant fibrosis and cirrhosis in patients with chronic hepatitis C. Hepatology 38, 518\u2013526. https:\/\/doi.org\/10.1053\/jhep.2003.50346 (2003).","journal-title":"Hepatology"},{"key":"54465_CR16","doi-asserted-by":"publisher","first-page":"102146","DOI":"10.1016\/j.aohep.2025.102146","volume":"31","author":"M Baven-Pronk","year":"2025","unstructured":"Baven-Pronk, M. et al. Aspartate aminotransferase\u2013to\u2013platelet ratio index (APRI) reliably excludes advanced fibrosis and cirrhosis in treated autoimmune hepatitis. Ann. Hepatol. 31, 102146. https:\/\/doi.org\/10.1016\/j.aohep.2025.102146 (2025).","journal-title":"Ann. Hepatol."},{"key":"54465_CR17","doi-asserted-by":"publisher","first-page":"503","DOI":"10.1016\/j.dld.2009.08.002","volume":"42","author":"JH Lee","year":"2010","unstructured":"Lee, J. H. et al. Hepatic steatosis index: a simple screening tool reflecting nonalcoholic fatty liver disease. Dig. Liver Dis. 42, 503\u2013508. https:\/\/doi.org\/10.1016\/j.dld.2009.08.002 (2010).","journal-title":"Dig. Liver Dis."},{"key":"54465_CR18","doi-asserted-by":"publisher","first-page":"1966","DOI":"10.1097\/HEP.0000000000000520","volume":"78","author":"ME Rinella","year":"2023","unstructured":"Rinella, M. E. et al. A multisociety Delphi consensus statement on new fatty liver disease nomenclature. Hepatology 78, 1966\u20131986. https:\/\/doi.org\/10.1097\/HEP.0000000000000520 (2023).","journal-title":"Hepatology"},{"key":"54465_CR19","doi-asserted-by":"publisher","first-page":"e6336","DOI":"10.1097\/MD.0000000000006336","volume":"96","author":"Q Li","year":"2017","unstructured":"Li, Q. et al. Evaluation of APRI and FIB-4 for noninvasive assessment of significant fibrosis and cirrhosis in HBeAg-negative CHB patients with ALT = 2 ULN: A retrospective cohort study<\/at. Med. (Baltim). 96, e6336. https:\/\/doi.org\/10.1097\/MD.0000000000006336 (2017).","journal-title":"Med. (Baltim)."},{"key":"54465_CR20","doi-asserted-by":"publisher","first-page":"1339","DOI":"10.1016\/j.jacc.2015.07.026","volume":"66","author":"TF Chao","year":"2015","unstructured":"Chao, T. F. et al. Age threshold for increased stroke risk among patients with atrial fibrillation: A nationwide cohort study from Taiwan. J. Am. Coll. Cardiol. 66, 1339\u20131347. https:\/\/doi.org\/10.1016\/j.jacc.2015.07.026 (2015).","journal-title":"J. Am. Coll. Cardiol."},{"key":"54465_CR21","doi-asserted-by":"publisher","first-page":"e008703","DOI":"10.1161\/JAHA.118.008703","volume":"7","author":"WA Huang","year":"2018","unstructured":"Huang, W. A., Dunipace, E. A., Sorg, J. M. & Vaseghi, M. Liver disease as a predictor of new-onset atrial fibrillation. J. Am. Heart Assoc. 7, e008703. https:\/\/doi.org\/10.1161\/JAHA.118.008703 (2018).","journal-title":"J. Am. Heart Assoc."},{"key":"54465_CR22","doi-asserted-by":"publisher","first-page":"5023","DOI":"10.1038\/s41598-020-61750-4","volume":"10","author":"HE Park","year":"2020","unstructured":"Park, H. E., Lee, H., Choi, S. Y., Kim, H. S. & Chung, G. E. The risk of atrial fibrillation in patients with non-alcoholic fatty liver disease and a high hepatic fibrosis index. Sci. Rep. 10, 5023. https:\/\/doi.org\/10.1038\/s41598-020-61750-4 (2020).","journal-title":"Sci. Rep."},{"key":"54465_CR23","doi-asserted-by":"publisher","first-page":"3322","DOI":"10.1016\/j.cgh.2023.04.026","volume":"21","author":"YG Seo","year":"2023","unstructured":"Seo, Y. G., Polyzos, S. A., Park, K. H. & Mantzoros, C. S. Fibrosis-4 index predicts long-term all-cause, cardiovascular and liver-related mortality in the adult Korean population. Clin. Gastroenterol. Hepatol. 21, 3322\u20133335. https:\/\/doi.org\/10.1016\/j.cgh.2023.04.026 (2023).","journal-title":"Clin. Gastroenterol. Hepatol."},{"key":"54465_CR24","doi-asserted-by":"publisher","unstructured":"Dusi, V., Ghidoni, A., Ravera, A., De Ferrari, G. M. & Calvillo, L. Chemokines and heart disease: A network connecting cardiovascular biology to immune and autonomic nervous systems. Mediat. Inflamm. 2016, 5902947. https:\/\/doi.org\/10.1155\/2016\/5902947 (2016).","DOI":"10.1155\/2016\/5902947"},{"key":"54465_CR25","doi-asserted-by":"publisher","first-page":"1717","DOI":"10.1093\/eurheartj\/ehw208","volume":"38","author":"PE Lazzerini","year":"2017","unstructured":"Lazzerini, P. E., Capecchi, P. L. & Laghi-Pasini, F. Systemic inflammation and arrhythmic risk: lessons from rheumatoid arthritis. Eur. Heart J. 38, 1717\u20131727. https:\/\/doi.org\/10.1093\/eurheartj\/ehw208 (2017).","journal-title":"Eur. Heart J."},{"key":"54465_CR26","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1161\/CIRCEP.107.754564","volume":"1","author":"S Nattel","year":"2008","unstructured":"Nattel, S., Burstein, B. & Dobrev, D. Atrial remodeling and atrial fibrillation: mechanisms and implications. Circ. Arrhythm. Electrophysiol. 1, 62\u201373. https:\/\/doi.org\/10.1161\/CIRCEP.107.754564 (2008).","journal-title":"Circ. Arrhythm. Electrophysiol."},{"key":"54465_CR27","doi-asserted-by":"publisher","first-page":"2731","DOI":"10.1093\/eurheartj\/eht194","volume":"34","author":"H Kottkamp","year":"2013","unstructured":"Kottkamp, H. Human atrial fibrillation substrate: towards a specific fibrotic atrial cardiomyopathy. Eur. Heart J. 34, 2731\u20132738. https:\/\/doi.org\/10.1093\/eurheartj\/eht194 (2013).","journal-title":"Eur. Heart J."},{"key":"54465_CR28","doi-asserted-by":"publisher","first-page":"933","DOI":"10.1161\/CIR.0b013e31820a55f5","volume":"123","author":"PA Heidenreich","year":"2011","unstructured":"Heidenreich, P. A. et al. Forecasting the future of cardiovascular disease in the United States: a policy statement from the American Heart Association. Circulation 123, 933\u2013944. https:\/\/doi.org\/10.1161\/CIR.0b013e31820a55f5 (2011).","journal-title":"Circulation"},{"key":"54465_CR29","doi-asserted-by":"publisher","first-page":"640","DOI":"10.1016\/j.jacbts.2019.05.005","volume":"4","author":"MJ Shen","year":"2019","unstructured":"Shen, M. J., Arora, R. & Jalife, J. Atrial myopathy. JACC Basic. Transl. Sci. 4, 640\u2013654. https:\/\/doi.org\/10.1016\/j.jacbts.2019.05.005 (2019).","journal-title":"JACC Basic. Transl Sci."},{"key":"54465_CR30","doi-asserted-by":"publisher","first-page":"1018","DOI":"10.1093\/europace\/euv036","volume":"17","author":"Z Mandalenakis","year":"2015","unstructured":"Mandalenakis, Z. et al. The risk of atrial fibrillation in the general male population: a lifetime follow-up of 50-year-old men. Europace 17, 1018\u20131022. https:\/\/doi.org\/10.1093\/europace\/euv036 (2015).","journal-title":"Europace"},{"key":"54465_CR31","doi-asserted-by":"publisher","first-page":"e2229799","DOI":"10.1001\/jamanetworkopen.2022.29799","volume":"5","author":"M Han","year":"2022","unstructured":"Han, M. et al. Habitual alcohol intake and risk of atrial fibrillation in young adults in Korea. JAMA Netw. Open. 5, e2229799. https:\/\/doi.org\/10.1001\/jamanetworkopen.2022.29799 (2022).","journal-title":"JAMA Netw. Open."},{"key":"54465_CR32","doi-asserted-by":"publisher","first-page":"e042003","DOI":"10.1161\/JAHA.125.042003","volume":"14","author":"M Kim","year":"2025","unstructured":"Kim, M., Son, M., Moon, S. Y. & Baek, Y. H. Metabolic dysfunction-associated steatotic liver disease, alcohol consumption, and the risk of atrial fibrillation: A nationwide population-based study. J. Am. Heart Assoc. 14, e042003. https:\/\/doi.org\/10.1161\/JAHA.125.042003 (2025).","journal-title":"J. Am. Heart Assoc."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-54465-5","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-54465-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-54465-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,26]],"date-time":"2026-07-26T23:01:06Z","timestamp":1785106866000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-54465-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,21]]},"references-count":32,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["54465"],"URL":"https:\/\/doi.org\/10.1038\/s41598-026-54465-5","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5,21]]},"assertion":[{"value":"6 March 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 May 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 May 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Lifelines study received ethical approval from the Medical Ethics Committee of the University Medical Center Groningen (METC UMCG, METc 2007\/152).","order":2,"name":"Ethics","label":"Ethics declarations","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Written informed consent was obtained from all participants of Lifelines study.","order":3,"name":"Ethics","label":"Consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"23268"}}